ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 241 filers reported holding ARRAY BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $520,000 | -54.3% | 11,232 | -75.9% | 0.01% | -58.3% |
| Q1 2019 | $1,138,000 | +73.7% | 46,658 | +1.4% | 0.01% | +50.0% |
| Q4 2018 | $655,000 | +25.2% | 45,995 | +33.7% | 0.01% | +33.3% |
| Q3 2018 | $523,000 | -70.7% | 34,402 | -67.6% | 0.01% | -75.0% |
| Q2 2018 | $1,782,000 | +1.9% | 106,211 | -0.9% | 0.02% | -14.3% |
| Q1 2018 | $1,748,000 | +388.3% | 107,126 | +268.2% | 0.03% | +300.0% |
| Q3 2017 | $358,000 | +33.1% | 29,092 | -3.3% | 0.01% | 0.0% |
| Q1 2017 | $269,000 | -47.3% | 30,100 | -48.1% | 0.01% | -66.7% |
| Q4 2016 | $510,000 | +146.4% | 58,000 | -0.2% | 0.02% | +61.5% |
| Q2 2016 | $207,000 | -46.9% | 58,100 | -37.2% | 0.01% | -69.8% |
| Q4 2015 | $390,000 | – | 92,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,850,650 | $75,330,000 | 5.64% |
| BVF INC/IL | 6,682,711 | $28,201,000 | 4.81% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,729,361 | $36,838,000 | 1.49% |
| First Light Asset Management, LLC | 530,391 | $2,238,000 | 0.94% |
| KOPP INVESTMENT ADVISORS LLC | 376,477 | $1,589,000 | 0.78% |
| Sarissa Capital Management LP | 700,000 | $2,954,000 | 0.57% |
| Orbimed Advisors | 10,689,000 | $45,108,000 | 0.41% |
| Bedell Frazier Investment Counselling, LLC | 178,971 | $755,000 | 0.37% |
| PINNACLE ASSOCIATES LTD | 3,453,487 | $14,574,000 | 0.31% |
| Artal Group S.A. | 3,710,000 | $15,656,000 | 0.29% |